ChromaDex Shares Jump on Tru Niagen's Launch In Walmart Stores

• ChromaDex Corp (NASDAQ: CDXC) has launched its flagship consumer product Tru Niagen in Walmart Inc (NYSE: WMT), available in 3,800 stores across the U.S.

• The NAD+ booster will be offered to Walmart customers in two distinct serving sizes, 100mg and 300mg.

• Tru Niagen is a form of vitamin B3 clinically proven to elevate NAD+, reducing the impact of aging and daily wear and tear on the body.

• NAD+ is a vital coenzyme naturally produced in the body, and studies have shown NAD+ declines up to 50% between the ages of 40 and 60.

• Based on a 300mg/day serving, Tru Niagen can increase NAD+ by 40-50%.

• Related content: ChromaDex CEO Rings Nasdaq Closing Bell, Talks Walmart Product Launch.

• Price Action: CDXC shares are up 11.7% at $9.99 during the market session on the last check Monday.

See more from Benzinga

• Click here for options trades from Benzinga

• Novartis's Iptacopan Aces Mid-Stage Kidney Disease Trial

• Harpoon's TriTAC Programs Show Reduction in Tumor Size, Stable Disease Across Solid Tumors

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.